2016 NCCN Nursing Program: Advancing Oncology Nursing

Hollywood, FL US
March 30, 2016

The NCCN 2016 Oncology Nursing Program at the NCCN 21st Annual Conference will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care. Information is focused on current and critical issues to provide oncology nurses with practical information that can be implemented in the practice setting. The program agenda includes the following topics: Survivorship, Anorexia and Cachexia, Sepsis and Global Oncology: Nursing Outreach Efforts.  Additionally, there will be two (2) concurrent sessions with simultaneous programs focusing on Clinical Updates and Issues for Metastatic Breast Cancer, T-Cell Lymphomas, Relapsed/Refractory Multiple Myeloma and Advanced Non-Small Cell Lung Cancer.

Target Audience

This program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

Survivorship: Managing Cardiac Toxicities
• Identify causes of cardiac toxicity in cancer survivors.
• Describe how cardiomyopathy following anthracycline therapy can be prevented.
• Discuss how nurses can encourage a healthy lifestyle in cancer survivors.

Nutrition Update: Anorexia and Cachexia
• List contributing causes of cancer cachexia.
• Outline the effects of anorexia and cachexia on cancer outcomes.
• Evaluate current and possible future treatment options for patients with cancer cachexia.

Clinical Updates and Issues: Metastatic Breast Cancer
• Describe the complexities in treating metastatic breast cancer.
• Outline new evidence-based systemic treatment recommendations for patients with metastatic breast cancer.
• Recognize and manage adverse events associated with newer treatment regimens for patients with metastatic breast cancer.

Clinical Updates and Issues: T-Cell Lymphomas
• Summarize the current and evolving therapeutic options for the treatment of T-cell lymphomas.
• Construct a treatment plan for the management of newly-diagnosed and relapsed PTCL.
• Discuss the role of stem-cell transplantation in treatment of T-cell lymphomas.

Clinical Updates and Issues: Relapsed/Refractory Multiple Myeloma
• Identify advances in systemic treatment of relapsed/refractory multiple myeloma.
• Describe the complexities in treating relapsed/refractory multiple myeloma.
• Recognize and manage adverse events associated with therapies used to treat relapsed/refractory multiple myeloma.

Clinical Updates and Issues: Advanced Non-Small Cell Lung Cancer
• Explain the complexities in treating advanced non-small cell lung cancer
• Analyze the potential of immunotherapies for treating advanced non-small cell lung cancer.
• Recognize and manage adverse events associated with therapies used to treat advanced non-small cell lung cancer.

Critical Care: Diagnosis and Management of Sepsis
• Recognize the signs of sepsis.
• Discuss the treatment of sepsis.
• Provide guidance regarding proper documentation of sepsis.

Global Oncology: Nursing Outreach Efforts
• Illustrate the need for global outreach efforts in oncology.
• Discuss the importance of nurses in global outreach efforts targeting cancer care.
• Outline the rewards and challenges associated with global outreach efforts targeting cancer care.

Additional information

Supported by educational grants from:

  • AstraZeneca
  • Celgene Corporation
  • Clovis Oncology
  • Genentech
  • Lilly
  • Novartis Oncology
  • Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC
  • Pfizer

This activity is supported by educational funding provided by Amgen.

Supported by an independent educational grant from Merck.


Last updated on 2/24/16.

Course summary
Available credit: 
  • 5.46 ANCC contact hours
  • 5.46 Participation
Course opens: 
Course expires: 
Event starts: 
03/30/2016 - 8:00am EDT
Event ends: 
03/30/2016 - 3:00pm EDT
The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. NCCN designates this educational activity for a maximum of 5.46 contact hours. Accreditation as a provider refers to the recognition of educational activities only; accredited status does not imply endorsement by NCCN or ANCC of any commercial products discussed/displayed in conjunction with the educational activity.

Kristina M. Gregory, RN, MSN, OCN, is our lead nurse planner for this educational activity.

Available Credit

  • 5.46 ANCC contact hours
  • 5.46 Participation


Please login or register to take this course.